Wed.Jun 12, 2024

article thumbnail

BMS chief Boerner says company is still hungry for deals after spending more than $20B on M&A last year

Fierce Pharma

As some pharma giants pump the brakes on big M&A deals, Bristol Myers Squibb—hot off a series of rapid-fire acquisitions in 2023—says it still has dealmaking cash to deploy if the right target | As some pharma giants pump the brakes on big M&A deals, Bristol Myers Squibb—hot off a series of rapid-fire acquisitions in 2023—says it still has dealmaking cash to deploy if the right target comes along.

Pharma 333
article thumbnail

Who Should Be Responsible for Rationing GLP-1s?

MedCity News

There is a shortage of GLP-1s in the U.S. But experts have differing opinions on whose responsibility it is to be rationing the drugs. The post Who Should Be Responsible for Rationing GLP-1s? appeared first on MedCity News.

114
114
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Amid FTC crackdown, judge says Teva inhaler patents are 'improperly listed' in FDA Orange Book

Fierce Pharma

After being called out on some intellectual property claims late last year, Teva has fallen victim to the Federal Trade Commission’s (FTC’s) ongoing crusade against questionable drug patents. | A federal judge in New Jersey ruled that five of Teva’s patents on the metered dose inhaler for its asthma med ProAir HFA are “improperly listed” in the FDA’s Orange Book.

FDA 309
article thumbnail

Avidity Bio’s RNA Therapy Flashes Early Signs of Treating a Muscular Dystrophy’s Root Cause

MedCity News

Avidity Biosciences’ RNA therapy for facioscapulohumeral muscular dystrophy has preliminary clinical data showing it knocked down expression of a gene that causes this rare disease. More details will be presented at a medical conference this week. The post Avidity Bio’s RNA Therapy Flashes Early Signs of Treating a Muscular Dystrophy’s Root Cause appeared first on MedCity News.

Medical 114
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Junshi, Coherus' PD-1 inhibitor Loqtorzi scores in phase 3 liver cancer trial

Fierce Pharma

Junshi revealed that a phase 3 trial of Loqtorzi plus Avastin prolonged the survival of first-line patients with hepatocellular carcinoma.

Patients 281
article thumbnail

Why Is Moon Surgical’s New Commercial Robot System Important?

MedCity News

This month, Moon Surgical received FDA clearance for the commercial version of its Maestro surgical robot system. The system is designed to support surgeons and other operating room staff, specifically for the 18.8 million annual soft tissue surgical procedures not currently supported by available telerobotic systems. The post Why Is Moon Surgical’s New Commercial Robot System Important?

FDA 114

More Trending

article thumbnail

Reimagining the Language and Translation Space for Patients

MedCity News

Lack of adequate translation and interpreting services isn’t just an inconvenience, it is dangerous and potentially life-threatening. The post Reimagining the Language and Translation Space for Patients appeared first on MedCity News.

Patients 111
article thumbnail

Data sharing will be key in repairing the UK clinical ecosystem

Pharmaceutical Technology

Lord James O'Shaughnessy, the former health minister, outlines places where the UK is falling behind other countries with clinical research.

105
105
article thumbnail

NICE declines to look again at depression drug Spravato

pharmaphorum

Johnson & Johnson has slammed a decision by NICE not to carry out a new appraisal of its antidepressant Spravato, claiming it has “grave concern” about access to new mental health treatments through NHS England.

92
article thumbnail

For Community Hospitals, Curing Payment Confusion Requires Patient Friendly Solutions

MedCity News

Strengthening patient financial education with the help of digital payment tools could be key to consumer engagement and cash recovery. The post For Community Hospitals, Curing Payment Confusion Requires Patient Friendly Solutions appeared first on MedCity News.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Behind the powerful computations, AI’s role in pharma is still beset by challenges

PharmaVoice

Small biotechs are saving time and money leveraging AI to develop new drugs, but incomplete data and disease complexity remain hurdles for the space.

Pharma 95
article thumbnail

ABPI embraces proposals for pharma’s growth ahead of UK elections

European Pharmaceutical Review

The Association of the British Pharmaceutical Industry (ABPI) has welcomed proposals from the Conservative and Unionist Party’s recently published Manifesto for the UK’s 2024 general election. We encourage other parties to come forward with equally specific proposals to boost the sector, so that the progress of recent years can be maintained” For example, this includes plans to accelerate NHS patient access to new medicines, which propose to “ remove bureaucratic obstacles to the use of

article thumbnail

New study reveals how brain cell communication is linked to Alzheimer’s disease

PharmaTimes

Two support cells, microglia and astrocytes, were found to communicate with each other

117
117
article thumbnail

Therapeutic Delivery for Brain-related Conditions

PharmaTech

At BIO 2024 in San Diego, John Dunlop, PhD, chief scientific officer at Aliada Therapeutics, sat down for an interview with Pharmaceutical Technology to discuss the firm’s MODEL platform and its potential impact on therapeutic delivery for brain-related conditions.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

ICL receives £10m donation to advance heart and lung research

PharmaTimes

The donation will help scientists and clinicians collaborate and make new advances in research

103
103
article thumbnail

Anti-obesity drugs will be 2024’s defining trend

Pharmaceutical Technology

GlobalData’s newest update notes the impact of the growing anti-obesity market, apersonalised medicines, real-world evidence, and cell and gene therapies.

article thumbnail

Pharma Pulse 6/12/24: The Healthcare System is Changing—So How Should We Respond?, What the Apple-OpenAI Deal Means for Four Tech Titans & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

Siegfried to boost drug substances offering with new acquisition

Pharmaceutical Technology

Siegfried has announced the signing of binding agreements with Curia Global to acquire an early-phase CDMO site in Grafton, Wisconsin, US.

81
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Flexibility in Outsourcing Models (BIO 2024)

PharmaTech

The PharmTech Group spoke with BIOVECTRA's director of Business Development, Nucleic Acid Modalities, Jessica Madigan, about the concept of flexibility in outsourcing and the 2024 BIO Convention.

52
article thumbnail

Study Suggests Individuals Born Preterm Are More Likely to Have Lower Incomes in Adulthood

PharmExec

Investigators followed a group of people born from 1990-1996 to assess whether the association between preterm birth and income differs according to family socioeconomic status at birth.

52
article thumbnail

Thinking outside of the box: Digitising pharmacy dispensing labels

Pharmaceutical Technology

Written Medicine is a digital solution that provides bilingual dispensing labels, described in a presentation at the NHS ConfedExpo conference in Manchester.

article thumbnail

Using OpenAI to Accelerate the Development and Launch of Upcoming mRNA Medicines

PharmExec

In this part of his Pharmaceutical Executive video interview, Brice Challamel, Vice President, AI Products & Platforms, Moderna, talks about how Moderna will leverage its collaboration with OpenAI to accelerate the development and launch of its upcoming mRNA medicines

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Determining the Source of Endocrine Therapy Nonadherence

Pharmaceutical Commerce

A retrospective cohort study investigates the characteristics of female patients with localized breast cancer that are associated with this nonpersistence.

article thumbnail

Succession Attack Plan: Get Strategic with Your Critical Roles

PharmExec

Outlining four considerations for biopharma companies in ensuring that their approach to replacing and filling key leadership positions is more truly aligned with future goals in business delivery and risk management.

article thumbnail

Study finds most patients in TARGET-NASH registry meet revised MASLD criteria

Pharmaceutical Technology

In 2023, MASLD replaced the umbrella term of nonalcoholic fatty liver disease (NAFLD) to avoid the potentially stigmatising language of the former name.

article thumbnail

AGC Biologics Completes Denmark Expansion to Double Single-Use Bioreactor Capacity

PharmaTech

The completed expansion at AGC Biologics'Copenhagen, Denmark, site, doubles the company's single-use bioreactor capacity for mammalian-based services.

52
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Despite adcomm rejection, Lykos CEO sees future for MDMA drug

PharmaVoice

Although the rebuff makes approval “a bit more challenging,” Lykos is moving forward with the psychedelic-based treatment for PTSD.

52
article thumbnail

AST’s Aseptic Fill/Finish Equipment

PharmaTech

AST’s VP of Business Development, Josh Russell, discusses the company’s impact on the pharmaceutical industry using innovative fill/finish equipment.

article thumbnail

A Novel Approach to Therapeutic Delivery Across the Blood-Brain Barrier

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Cyrus Biotechnology to spin out Levitate Bio for biopharma AI

Pharmaceutical Technology

Software-enabled biotechnology company Cyrus Biotechnology has announced the spinout of Levitate Bio to enhance biopharma AI offerings.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.